文献速递痛风与晶体性关节病

ABCG2 rs2231142 与别嘌醇反应不佳的关联:重复验证与荟萃分析

Association between ABCG2 rs2231142 and poor response to allopurinol: replication and meta-analysis.
PubMed 文献 · Rheumatology (Oxford) · 2018-01-01

在痛风患者中重复验证 ABCG2 rs2231142 和 rs10011796 与别嘌醇反应不佳的关联,LASSO 队列 299 例,联合新西兰痛风遗传学研究 296 例进行荟萃分析;rs2231142 与别嘌醇反应不佳显著相关(OR=2.43,P=6.2×10⁻⁷),rs10011796 无显著关联。

要点

  • ABCG2 rs2231142 与别嘌醇反应不佳显著相关,荟萃分析 OR=2.43(P=6.2×10⁻⁷)。
  • ABCG2 rs10011796 与别嘌醇反应不佳无显著关联,荟萃分析 OR=1.06(P=0.69)。
  • LASSO 队列中 rs2231142 的 OR=2.35(P=7.3×10⁻⁴),rs10011796 的 OR=1.21(P=0.33)。

核心结论

  • 本研究证实 ABCG2 rs2231142 与别嘌醇反应不佳存在显著关联。

研究设计与样本

  • 纳入长期别嘌醇安全性评估痛风患者结局研究(LASSO)299 例参与者,并在有治疗依从性证据(血浆氧嘌呤醇 >20 μmol/l)的患者中分析。
  • 将 LASSO 研究与新西兰痛风遗传学研究中的 296 例参与者(其中 264 例来自已发表报告)的结果通过荟萃分析合并。
  • 采用纳入年龄、性别、BMI、种族和估算肾小球滤过率的 logistic 回归模型检验 rs2231142 和 rs10011796 与反应不佳的关联。

主要发现

  • 在 LASSO 队列的校正 logistic 回归模型中,rs2231142 与别嘌醇反应存在关联证据(OR=2.35,P=7.3×10⁻⁴),rs10011796 无关联证据(OR=1.21,P=0.33)。
  • 荟萃分析提供 rs2231142 与别嘌醇反应显著关联的证据(OR=2.43,P=6.2×10⁻⁷),rs10011796 无显著关联(OR=1.06,P=0.69)。

关键数值与推荐

  • 良好反应定义为别嘌醇 ≤300 mg/天时血清尿酸 <6 mg/dl;反应不佳定义为别嘌醇 >300 mg/天时血清尿酸 ≥6 mg/dl。
  • 治疗依从性证据定义为血浆氧嘌呤醇 >20 μmol/l。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: ABCG2 rs2231142 (Q141K) has been reported to be associated with poor response to allopurinol, while there are conflicting data on the association between the genetically independent ABCG2 rs10011796 variant and allopurinol response. The aim of this study was to replicate the association of ABCG2 rs2231142 and rs10011796 with allopurinol response and perform a meta-analysis. METHODS: Participants in the Long-term Allopurinol Safety Study Evaluating Outcomes in Gout Patients (LASSO) (n = 299) were studied. In patients with evidence of adherence to allopurinol therapy (plasma oxypurinol >20 μmol/l), good response was defined as serum urate <6 mg/dl on allopurinol ⩽300 mg/day and poor response as serum urate ⩾ 6 mg/dl despite allopurinol >300 mg/day. Association of rs2231142 and rs10011796 with poor response was tested in logistic regression models that included age, sex, BMI, ethnicity and estimated glomerular filtration rate. Results from the LASSO study and a subset of participants in the Genetics of Gout in Aotearoa New Zealand study (n = 296, including 264 from a previously published report) were combined by meta-analysis. RESULTS: There was evidence for association of rs2231142 with allopurinol response [odds ratio (OR) = 2.35, P = 7.3 × 10-4] but not for rs10011796 (OR = 1.21, P = 0.33) in the LASSO cohort using an adjusted logistic regression model. Meta-analysis provided evidence of a significant association of rs2231142 with allopurinol response (OR = 2.43, P = 6.2 × 10-7), but not rs10011796 (OR = 1.06, P = 0.69). CONCLUSION: This study has confirmed the significant association of ABCG2 rs2231142 with poor response to allopurinol.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Wallace MC, Roberts RL, Nanavati P, et al. Association between ABCG2 rs2231142 and poor response to allopurinol: replication and meta-analysis. Rheumatology (Oxford). 2018. PMID: 29342288. doi:10.1093/rheumatology/kex467

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。